Patients who smoke and undergo early lung cancer screening may not feel the need to stop smoking.
Early lung cancer screening may negatively impact smoking cessation efforts, according to a study published in JAMA Internal Medicine.
Researchers from the VA Puget Sound Health Care System, University of Washington, Fred Hutchinson Cancer Research Center, Swedish Medical Group, and Swedish Medical Center in Seattle, performed an ancillary study to the launch of a lung cancer screening program to determine if views on smoking cessation were affected by the availability of routine early lung cancer screening. The study took place from May 29 to September 22, 2014.
A total of 45 semi-structured qualitative interviews about health beliefs related to smoking and lung cancer screening were administered by phone to 37 current smokers who had been offered lung cancer screening.
The researchers found that while receiving a diagnosis of lung cancer does prompt most smokers to consider their smoking habit and its relationship to their health, 49% of the patients in the study (17 of 35 patients) said that early screening lowered their concern and motivation to quit smoking. Reported misconceptions included:
• Undergoing an imaging test yields the same health benefits as smoking cessation
• Everyone who participates in screening will benefit
• Screening and additional screening as needed offers protection from lung cancer[[{"type":"media","view_mode":"media_crop","fid":"40206","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_3148405701657","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4092","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©atichart wongubon/Shutterstock.com","typeof":"foaf:Image"}}]]
• Findings from screenings have saved lives by catching cancer early when indeterminate findings are identified that can be monitored rather than immediately treated
• A cancer-free screening test result indicates that they are among the lucky ones who will avoid the harms of smoking
The researchers concluded that how clinicians speak to their patients about early lung cancer screening can have a significant effect on the patients’ interpretations of the need for smoking cessation. “Health care professionals should be aware that the opportunity for early detection of lung cancer may be interpreted as a way of avoiding the harms of smoking,” they wrote. “To promote cessation, discussions should focus on the emotional response to screening rather than clinical details (eg, nodule size) and address misperceptions about the value of early detection so that screening does not lower motivation to quit smoking.”
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.